Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4757309
Max Phase: Preclinical
Molecular Formula: C14H15ClF2N6O3
Molecular Weight: 388.76
Molecule Type: Unknown
Associated Items:
ID: ALA4757309
Max Phase: Preclinical
Molecular Formula: C14H15ClF2N6O3
Molecular Weight: 388.76
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Nc1nc(Cl)nc2c1ncn2[C@H]1[C@H](O)[C@H](O)[C@]2(C(=O)NCC(F)F)C[C@H]12
Standard InChI: InChI=1S/C14H15ClF2N6O3/c15-13-21-10(18)6-11(22-13)23(3-20-6)7-4-1-14(4,9(25)8(7)24)12(26)19-2-5(16)17/h3-5,7-9,24-25H,1-2H2,(H,19,26)(H2,18,21,22)/t4-,7-,8+,9+,14+/m1/s1
Standard InChI Key: BSCDUXJFTLEDRY-RKQMVLKSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 388.76 | Molecular Weight (Monoisotopic): 388.0862 | AlogP: -0.27 | #Rotatable Bonds: 4 |
Polar Surface Area: 139.18 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.16 | CX Basic pKa: 2.38 | CX LogP: -0.92 | CX LogD: -0.92 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.53 | Np Likeness Score: 0.05 |
1. Tosh DK,Brackett CM,Jung YH,Gao ZG,Banerjee M,Blagg BSJ,Jacobson KA. (2021) Biological Evaluation of 5'-(N-Ethylcarboxamido)adenosine Analogues as Grp94-Selective Inhibitors., 12 (3): [PMID:33738064] [10.1021/acsmedchemlett.0c00509] |
Source(1):